Benzohexonium-Health solution for injection 2.5% ampoule 1 ml No. 10

Benzohexonium-Health injection solution is used for the following indications:

Composition

1 ml of solution contains (active ingredient) benzohexonium 25 mg.

The excipient is water for injection.

Contraindication

Method of application

Administer intramuscularly, intravenously or subcutaneously. The dosage regimen is individual due to the large individual variability of patient reactions.

Before starting therapy, it is necessary to conduct a test for individual sensitivity, for which ½ of the average dose should be administered (by the selected route of administration) and the patient's condition should be monitored.

Adults

Controlled hypotension: administer 1-1.5 ml (25-37.5 mg) over 2 minutes.

Hypertensive crisis. For relief, administer 0.5-1 ml (12.5-25 mg) intramuscularly or subcutaneously. If necessary, repeated injections can be performed (3-4 times a day).

Spasms of peripheral vessels: administer intramuscularly or subcutaneously 0.25-0.5 ml (6.25-12.5 mg) 1 hour before meals 2-4 times a day. Treatment is carried out in courses of 2-4-6 weeks with breaks of 1-3 weeks.

Maximum doses for adults for intramuscular and subcutaneous administration: single dose - 3 ml (75 mg), daily dose - 12 ml (300 mg).

Since the effect of benzohexonium gradually decreases with repeated administration, treatment should be started with small doses and then the doses should be gradually increased.

Children

In children in emergency cases, administer intramuscularly or intravenously. Administer intravenously slowly (over 6-8 minutes), dissolving in 10-20 ml of 0.9% sodium chloride or glucose solution. Single doses for children: up to 2 years - 0.04-0.08 ml/kg (1-2 mg/kg), 2-4 years - 0.02-0.08 ml/kg (0.5 2 mg/kg), from 5 years - 0.02 ml/kg (0.5 mg/kg).

Application features

Pregnant women

The drug is contraindicated for use during pregnancy. If necessary, use of the drug should be discontinued breastfeeding.

Drivers

During treatment, you should refrain from driving vehicles and performing potentially dangerous activities due to the possibility of developing side effects from the nervous and cardiovascular systems.

Overdose

Overdose may cause orthostatic collapse.

Treatment: place the patient in a position with the head down and legs raised; administration of mezaton or ephedrine in small doses, cordiamine, and caffeine is indicated.

Side effects

On the part of the heart: increased pulse, tachycardia, pain in the heart area.

From the nervous system: weakness, dizziness, dilated pupils, accommodation disorders, short-term memory loss, dysarthria, respiratory depression.

On the part of the digestive system: dry mouth, dysphagia, constipation; with prolonged use - intestinal atony and gallbladder paresis.

From the urinary system: with prolonged use - bladder atony, urination disorders with urine stagnation, which contributes to the development of cystitis.

Vascular: orthostatic hypotension (up to the development of collapse), sclera vascular injections.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 °C, out of the reach of children.

Shelf life - 4 years.